Antiplatelet use in interventional cardiology

Area of Science:

• Cardiovascular Medicine
• Hematology
• Interventional Cardiology

Background:

• Thrombosis in coronary intervention is a significant clinical concern.
• Platelet activation and aggregation are key mechanisms driving this complication.
• Severe adverse clinical outcomes are frequently associated with coronary artery thrombosis.

Purpose of the Study:

• To highlight the role of platelet inhibition in managing coronary intervention complications.
• To emphasize the current therapeutic strategies for preventing thrombosis.
• To discuss the benefits of multi-agent antiplatelet therapy.

Main Methods:

• Review of current literature on coronary intervention and thrombosis.
• Analysis of the mechanisms of platelet activation and aggregation.
• Evaluation of antiplatelet therapy regimens, including dual and triple therapy.

Main Results:

• Platelet activation is central to thrombosis following coronary intervention.
• The use of multiple antiplatelet agents is now standard practice, particularly with intracoronary stents.
• Current antiplatelet strategies have shown success in mitigating adverse clinical events.

Conclusions:

• Inhibiting platelet function is crucial for reducing complications after coronary intervention.
• Multi-agent antiplatelet therapy is effective in managing thrombosis risk.
• Adherence to recommended antiplatelet regimens improves patient outcomes.